Leveraging the dual role of ROS in liver diseases with nanomaterials: clearing and amplifying for therapy

Nanoscale. 2025 Jan 2. doi: 10.1039/d4nr04469j. Online ahead of print.

Abstract

The dual role of reactive oxygen species (ROS) in various liver diseases leads to the potential of nanomaterials in addressing challenges related to liver conditions. Considering the pivotal role of ROS in liver disease progression, the design and application of nanomaterials need to align with distinct disease characteristics and the unique liver microenvironment. By reviewing the interaction between nanomaterials and ROS in liver diseases and their potential applications in liver disease treatment, this work discusses the multifaceted properties of nanomaterials and their high specificity and prospects in liver disease treatments.

Publication types

  • Review